Finanzwire Finanzwire
Basculer en Français
10938 Companies
238839 Keywords
167680 Articles
128375 Press releases
Headlines Articles Press releases Experimental Biology And Medicine Remove
  1. Home
  2. Companies
  3. Experimental Biology And Medicine
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 06/18/2024 at 15:05, 2 years 2 months ago

    New Study Examines How Topical Naltrexone Restores Tear Production in Diabetic Dry Eye

    Diabetic Dry Eye Naltrexone Tear Production OGF-OGFr Pathway Ocular Complications
  • PRESS RELEASE

    published on 06/18/2024 at 15:00, 2 years 2 months ago

    New Study Examines How Topical Naltrexone Restores Tear Production in Diabetic Dry Eye

    Study led by Dr. Pat McLaughlin reveals topical naltrexone's effectiveness in reversing dry eye in diabetic rats. Findings point to OGF-OGFr pathway blockade as a promising treatment approach
    Diabetes Experimental Biology And Medicine Naltrexone OGF-OGFr Pathway Dry Eye
    Logo of Experimental Biology And Medicine
  • BRIEF

    published on 04/03/2024 at 15:05, 2 years 5 months ago

    HTERT Vaccine Shows Promise in Therapy-Resistant Cancer Patients, Study Finds

    Cancer Immunotherapy HTERT Vaccination Therapy-resistant Cancer Immune Response King's College London
  • PRESS RELEASE

    published on 04/03/2024 at 15:00, 2 years 5 months ago

    Study Shows hTERT Vaccination Induces Immunological Responses and Prevents Progression in a Subset of Therapy-Resistant Poor Prognosis Cancer Patients

    A Phase 1 clinical trial led by James Spicer at King's College London showcases promising developments in immune therapy for solid tumours via hTERT vaccination. Published in Experimental Biology and Medicine
    Solid Tumors Clinical Trial HTERT Vaccination Immune Therapy Experimental Biology And Medicine
    Logo of Experimental Biology And Medicine
Accesswire
  • Published on 09/05/2026 at 04:05, 1 day 3 hours ago

    Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update

  • Published on 09/04/2026 at 23:30, 1 day 8 hours ago

    FutureGen Industries Announces Shares for Debt Settlement

  • Published on 09/04/2026 at 23:00, 1 day 8 hours ago

    Golden Minerals Announces Management Change and Argentine Project Update

  • Published on 09/04/2026 at 22:30, 1 day 9 hours ago

    Panther Minerals Closes Brokered Private Placement of $3,000,000

  • Published on 09/04/2026 at 14:30, 1 day 17 hours ago

    Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)

View all ACCESSWIRE
EQS Group
  • Published on 09/06/2026 at 06:00, 1 hour 30 minutes ago

    CoolFly to Showcase Personal Flight Portfolio and NA80 Flight-Control Technology at IFA Berlin 2026

  • Published on 09/06/2026 at 05:15, 2 hours 15 minutes ago

    Experience AI Companion in Everyday Life at Hisense IFA 2026

  • Published on 09/05/2026 at 22:20, 9 hours 10 minutes ago

    PITAKA Marks Its Next Chapter in Berlin With "Signals in the Wind," Unveiling New iPhone 18 Accessories

  • Published on 09/05/2026 at 19:35, 11 hours 55 minutes ago

    ToolDance Unveils X1 Smart Desktop CNC Mill at IFA 2026

  • Published on 09/05/2026 at 14:00, 17 hours 30 minutes ago

    Global investment boom could create USD 200 billion commercial insurance opportunity amid rising accumulation risks, finds Swiss Re Institute

View all EQS
Les Echos
  • Published on 09/04/2026 at 18:57, 1 day 12 hours ago

    Disclosure of transactions in own shares from September 1 to September 4, 2026

  • Published on 09/04/2026 at 17:45, 1 day 13 hours ago

    Declaration of voting rights at the end of August 2026

  • Published on 09/04/2026 at 17:45, 1 day 13 hours ago

    DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

  • Published on 09/04/2026 at 16:00, 1 day 15 hours ago

    Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2026

  • Published on 09/04/2026 at 16:00, 1 day 15 hours ago

    Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2026

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy